Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04061603 · ClinicalTrials.gov registry record · NA
iCLAS™ for Persistent Atrial Fibrillation
A NA study, sponsored by Adagio Medical.
- Completed
- Registry status
- NA
- Development phase
- 215
- Enrollment target
NCT04061603 is a NA study that has completed, run by Adagio Medical. The registered enrollment target is 215 participants.
The verdict
NCT04061603, a NA study, has completed, sponsored by Adagio Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 215 participants
- Enrollment target
Study Summary
Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)
Interventions
- DEVICE Adagio AF Cryoablation System (iCLAS™)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04061603
The ClinicalTrials.gov registry entry for NCT04061603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adagio Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adagio AF Cryoablation System (iCLAS™) is the first listed.
NCT04061603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04061603 about?
NCT04061603 is a clinical study titled "iCLAS™ for Persistent Atrial Fibrillation". Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)
What is the current status of trial NCT04061603?
This trial is currently completed. It is a NA study. The enrollment target is 215 participants. The study started on 2019-12-09. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT04061603?
The interventions under investigation include: Adagio AF Cryoablation System (iCLAS™) (DEVICE).
Who is sponsoring clinical trial NCT04061603?
This trial is sponsored by Adagio Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.